Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38833 for Org 36286 (Corifollitropin Alfa).
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Corifollitropin alfa (Primary)
- Indications Infertility
- Focus Adverse reactions
- Sponsors Organon; Schering-Plough
- 11 Oct 2008 End date changed from 1 Oct 2008 to 1 Jan 2008 as reported by CT.gov
- 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2008 New trial record.